RxDoctor Payments Data

Chi Hung, MD

Critical Care Medicine · Seattle, WANPI 1841376118

Payments from drug & device makers

What this record shows

That places this record below the midpoint for critical care medicine clinicians in WA, where the typical reported total is $138.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$724,970in research payments, 2019–2025

Across 5 payments — averaging $144,994 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$379K
  • Boehringer Ingelheim$346K

How this compares

$0 in reported general payments places this provider in the 0th percentile of 115 critical care medicine providers in Washington.

See all critical care medicine providers in Washington

Medicare billing

Part B allowed, 2024
$22,505
Medicare patients
82
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mycophenolate Mofetil22$1,728
Prednisone27$216

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →